22 Jul 2023

HKSTP Partner Companies HKRM and Cordlife Sign Collaboration Agreement To Advance Stem Cell Therapy and Improve Awareness of Regenerative Medicine

Hong Kong Science and Technology Parks Corporation (HKSTP) partner companies Hong Kong Regen MedTech Limited (HKRM) and Cordlife Hong Kong Limited (Cordlife) announced their partnership to co-launch a regenerative medical project focused on Mesenchymal Stem Cells (MSCs) biology.

Key Takeaways

  • Under the “Medtech Co-Create” programme of HKSTP, partner companies HKRM and Cordlife formed a partnership to launch collaborative projects involving regenerative medicine for osteoarthritis patients.
  • HKSTP is currently home to over 200 biotech companies and over 1,200 researchers from 12 countries, covering fields such as Food Tech, Nutraceutics, Cosmetics, Traditional Chinese Medicine, Medical Devices, Stem Cell & Regenerative Medicine and Therapeutics.